CEO, Rohan Greenland discusses MS Australia's seven-point plan for the federal election, together with our biggest annual fundraiser for MS research – The May 50K.
A new vaccine combination targeting two pathways of Epstein Barr virus (EBV) entry into human cells is progressing towards clinical development, taking us one step closer to understanding the complex association between MS and EBV.
World MS Day brings the global MS community together on May 30 to share stories, raise awareness and campaign with and on behalf of everyone affected by multiple sclerosis (MS).
A recent issue of the Australian Journal of General Practice has raised awareness about MS symptoms, recommendations for managing MS and understanding the lived experience of people with MS.
A new paper from the International Progressive MS Alliance calls for a coordinated global approach to answering important questions on COVID-19 in progressive MS.
A new report by MS Australia reveals that MS Nurse care improves health outcomes, but one-third of Australians living with MS do not have access to this life-changing support.
MS researchers, clinicians and allied healthcare professionals met in Hobart this month to present their latest findings and form research collaborations.
We believe that in the next term of government, there is an opportunity for our political leaders and decision-makers to make an impact on improving the lives of people with MS, their carers, families and friends.
The Australian MS Longitudinal study has explored the impact of MS for 20 years, identifying unmet needs and gathering evidence to improve quality of life.
An emerging body of work has suggested that people with certain chronic illnesses affecting cognitive function may be more vulnerable to oral health (dental) issues.
